iShares U.S. Pharmaceuticals ETF Rating → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free IHE Stock Alerts $65.81 +0.48 (+0.73%) (As of 11:38 AM ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy2.59Holdings in IHE have an aggregate rating of Moderate Buy based on 259 analyst ratings issued in the past year covering 33 companies (99.5% of the portfolio).IHE Aggregate Price Target$80.0122.48% UpsideHigh Prediction$99.87Average Prediction$80.01Low Prediction$63.06Holdings in IHE have an aggregate price target of $80.01 and a range of $63.06 to $99.87 covering 33 companies (99.5% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 33 IHE Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings22.75%LLYEli Lilly and Company$775.09-0.3%5 of 5 stars2.84$757.95 -2.2%19Earnings ReportDividend Announcement22.67%JNJJohnson & Johnson$149.03+0.2%5 of 5 stars2.46$175.86 18.0%13Analyst Forecast4.97%MRKMerck & Co., Inc.$129.95-0.3%5 of 5 stars2.58$131.33 1.1%124.67%PFEPfizer$28.11+1.2%5 of 5 stars2.38$36.00 28.1%16Earnings ReportAnalyst Revision4.63%RPRXRoyalty Pharma$28.14-0.5%5 of 5 stars3.00$46.75 66.1%4Upcoming EarningsNews Coverage4.50%VTRSViatris$11.92+1.7%0 of 5 stars1.33$11.00 -7.7%3Upcoming Earnings4.48%BMYBristol-Myers Squibb$43.76-0.6%5 of 5 stars2.11$60.00 37.1%194.30%CTLTCatalent$56.42-0.2%3 of 5 stars2.15$52.46 -7.0%13Analyst Forecast3.90%ZTSZoetis$164.17-2.5%5 of 5 stars3.00$212.38 29.4%7Earnings ReportAnalyst ForecastAnalyst Revision2.98%ITCIIntra-Cellular Therapies$69.63-2.2%5 of 5 stars2.90$90.17 29.5%10Earnings ReportAnalyst ForecastNews Coverage2.97%JAZZJazz Pharmaceuticals$110.35-0.8%5 of 5 stars2.85$192.75 74.7%13Insider Selling2.74%ELANElanco Animal Health$16.92+25.1%3 of 5 stars2.57$16.71 -1.2%7Gap Up1.95%OGNOrganon & Co.$20.38-0.1%5 of 5 stars2.50$22.60 10.9%4Dividend Announcement1.79%PRGOPerrigo$30.78+2.1%5 of 5 stars3.00$40.67 32.1%3Earnings ReportDividend AnnouncementNews CoverageGap Down1.48%PBHPrestige Consumer Healthcare$70.52+0.8%4 of 5 stars2.50$110.00 56.0%2Upcoming EarningsAnalyst RevisionPositive News1.13%AXSMAxsome Therapeutics$75.90-1.4%4 of 5 stars2.92$122.17 61.0%13Analyst ForecastAnalyst RevisionNews Coverage1.01%ARVNArvinas$33.31-3.0%3 of 5 stars2.88$61.33 84.1%16Earnings ReportAnalyst ForecastNews CoverageGap Down0.89%CORTCorcept Therapeutics$24.57+0.4%5 of 5 stars3.00$40.10 63.2%4Earnings ReportInsider SellingAnalyst Revision0.69%SUPNSupernus Pharmaceuticals$31.13-0.1%4 of 5 stars3.00$41.00 31.7%10.64%AMPHAmphastar Pharmaceuticals$42.86+0.2%5 of 5 stars2.50$66.00 54.0%40.52%PCRXPacira BioSciences$29.89+12.7%5 of 5 stars3.00$49.50 65.6%10Analyst ForecastNews Coverage0.51%LGNDLigand Pharmaceuticals$79.97+9.2%5 of 5 stars3.00$116.33 45.5%3Earnings ReportAnalyst ForecastNews Coverage0.49%COLLCollegium Pharmaceutical$37.76+1.2%2 of 5 stars2.60$39.00 3.3%5Upcoming Earnings0.42%ANIPANI Pharmaceuticals$66.44-0.4%5 of 5 stars3.00$80.00 20.4%4Upcoming Earnings0.42%EWTXEdgewise Therapeutics$21.43+0.9%1 of 5 stars3.00$31.20 45.6%5Upcoming Earnings0.41%HRMYHarmony Biosciences$31.38+0.1%4 of 5 stars2.50$40.63 29.5%8Gap Up0.37%TARSTarsus Pharmaceuticals$37.91-0.3%3 of 5 stars2.88$48.38 27.6%8Upcoming Earnings0.33%SAVACassava Sciences$23.16+6.1%3 of 5 stars3.00$124.00 435.4%10.28%PLRXPliant Therapeutics$13.36-3.1%4 of 5 stars3.00$45.67 241.8%10Analyst ForecastNews Coverage0.26%AMRXAmneal Pharmaceuticals$6.65+2.2%1 of 5 stars3.00$8.25 24.1%4Analyst Forecast0.14%TBPHTheravance Biopharma$9.60+0.6%1 of 5 stars3.00$20.50 113.5%2Upcoming Earnings0.14%RVNCRevance Therapeutics$4.30-1.8%4 of 5 stars2.50$13.75 219.8%8Upcoming Earnings0.03%AMLXAmylyx Pharmaceuticals$1.96-0.5%4 of 5 stars2.25$32.67 1,566.7%8Upcoming Earnings This page (NYSEARCA:IHE) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
